Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-11-02Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab [Phase 3]
Phase 3 trial evaluating Avastin (bevacizumab) with mFOLFOX6 for treatment-naïve metastatic colorectal cancer (± KRAS mutations) has been wi…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics
This is a completed non-interventional study sponsored by Hoffmann-La Roche that assesses the occurrence rates of several cancers in Turkey …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer [Phase 4]
A Phase 4 clinical trial evaluating capecitabine (Xeloda) as adjuvant therapy after surgical resection of colon cancer. The study has comple…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer [Phase 4]
This document reports the completion of a Phase 4 clinical trial evaluating capecitabine (Xeloda) in patients with metastatic colorectal can…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer [NA]
A completed clinical trial evaluating whether a low-fiber or high-fiber diet reduces bowel-related side effects in patients undergoing radia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Evaluation of CTCs Combined With Tumor Marker Detection of Efficacy of Chemotherapy in mCRC
This item reports an update on a clinical trial evaluating whether combining circulating tumor cells with tumor marker detection can assess …
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors [NA]
A clinical trial from University Hospital Tuebingen compares short-term starvation versus a normal diet before chemotherapy in solid tumors;…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia [Phase 4]
Phase 4 trial IVICA evaluating intravenous iron for colorectal cancer-associated anemia has completed. The study was sponsored by Nottingham…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma [Phase 2]
Phase 2 trial evaluating FOLFIRI with AMG 479 or AMG 655 versus FOLFIRI alone in KRAS-mutant metastatic colorectal cancer; the study has com…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer [Phase 2]
Phase 2 trial evaluating transarterial chemoembolization with irinotecan drug-eluting beads in combination with intravenous cetuximab for re…
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Supportive Cancer Care Networkers (SCAN) [NA]
The Supportive Cancer Care Networkers (SCAN) trial evaluating supportive care for colorectal cancer patients undergoing chemotherapy has com…
-
CLINICAL_TRIALS research · 2016-10-20Clinical Trial Update: Study of Association Between Peripheral Immune Cells and Recurrence in Stage II/III Colorectal Cancer
This clinical trial update examines whether peripheral immune cell profiles are associated with recurrence in stage II/III colorectal cancer…
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC) [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the MEK inhibitor MSC1936369B in combination with FOLFIRI in second-line KRAS-mutated metastatic colorectal can…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum. [Phase 3]
A Phase 3 trial evaluating bevacizumab in combination with chemotherapy for metastatic colorectal cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients [Phase 3]
Phase 3 study comparing FOLFIRI against Irinotecan as second-line treatment for metastatic colorectal cancer.
-
CLINICAL_TRIALS research · 2016-10-17Clinical Trial Update: FIT Mailing Protocol-For Cancer Screening Navigation [NA]
Clinical trial update for a colorectal cancer screening navigation study (NCT02934958) sponsored by Renown Regional Medical Center; the curr…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency [Phase 2]
Phase 2 clinical trial evaluating methotrexate in advanced/metastatic colorectal cancer with MSH2 deficiency has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers [Phase 1]
This entry covers a Phase 1 safety study of a human MUC-1 adenoviral vector vaccine designed for immunotherapy of epithelial cancers. The st…
-
CLINICAL_TRIALS trial_result · 2016-10-13Clinical Trial Update: Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis [Phase 2]
Phase 2 trial evaluating bevacizumab (AVASTIN) with stereotactic body radiotherapy for colorectal liver metastases has completed, exploring …
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer [Phase 3]
Phase 3 trial evaluating neoadjuvant chemoradiation with capecitabine, with or without oxaliplatin, followed by surgery in locally advanced …
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases [Phase 2]
Phase 2 trial evaluating FOLFOX alone, FOLFOX with bevacizumab, and FOLFOX with panitumumab in patients with resectable liver metastases fro…
-
FDA approval · 2016-10-11FDA Approved: ERBITUX — Supplemental Application (ImClone LLC)
The FDA approves a supplemental application for Erbitux (cetuximab) filed by ImClone LLC.
-
CLINICAL_TRIALS research · 2016-10-10Clinical Trial Update: Diagnostic Potential of Hypermethylated DNA in Colorectal Cancer
An update on a clinical trial evaluating hypermethylated DNA as a diagnostic biomarker for colorectal cancer.
-
CLINICAL_TRIALS research · 2016-10-05Clinical Trial Update: ANC1 Study Impact of a Geriatric and Nutritional Evaluation for the Malnutrition and Malnutrition Risk Screening in Patients Over 70 Years With Colorectal Surgery. [NA]
An update on the ANC1 study assessing geriatric and nutritional evaluation to screen for malnutrition risk in patients over 70 undergoing co…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating an NY-ESO-1 vaccine therapy with or without sirolimus in patients whose tumors express NY-ESO-1.